rs397517755
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001267550.2(TTN):c.92451G>T(p.Glu30817Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,613,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.92451G>T | p.Glu30817Asp | missense_variant | Exon 339 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.92451G>T | p.Glu30817Asp | missense_variant | Exon 339 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 248686Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134920
GnomAD4 exome AF: 0.0000739 AC: 108AN: 1461524Hom.: 0 Cov.: 34 AF XY: 0.0000770 AC XY: 56AN XY: 727032
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74308
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:1
- -
- -
- -
- -
- -
not specified Uncertain:2
Variant summary: TTN c.84747G>T (p.Glu28249Asp) results in a conservative amino acid change located in the A band domain of the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 248686 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.84747G>T has been reported in a cohort of non-compaction cardiomyopathy patients and authors classified the variant as VUS (example: van Waning_2018). This report does not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely benign, and as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance -
The Glu28249Asp variant (TTN) has not been reported in the literature nor previo usly identified by our laboratory. Glutamic acid (Glu) at position 28249 is con served in evolution, suggesting that a change may impact the protein. Other com putational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, an d SIFT) do not provide strong support for or against an impact to the protein. Additional information is needed to fully assess the clinical significance of th e Glu28249Asp variant. -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.E21752D variant (also known as c.65256G>T), located in coding exon 166 of the TTN gene, results from a G to T substitution at nucleotide position 65256. The glutamic acid at codon 21752 is replaced by aspartic acid, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at